We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Simple Blood Test Could Make It Easier to Diagnose Epilepsy

By LabMedica International staff writers
Posted on 14 Mar 2023
Print article
Image: Epilepsy could now become easier to pinpoint with a blood test (Photo courtesy of Pexels)
Image: Epilepsy could now become easier to pinpoint with a blood test (Photo courtesy of Pexels)

Epilepsy refers to abnormal activity in the brain that results in temporary loss of control of behavior and movement. This condition can be congenital, caused by a tumor, stroke, or brain infection, and produce varying symptoms based on the affected region of the brain. Diagnosing epilepsy can be a challenging and resource-intensive process, and differentiating it from other conditions is often difficult. As such, there exists a pressing need to develop better diagnostic tools, particularly for use early on after a suspected seizure. Now, researchers have discovered higher levels of immune proteins in the blood before and after an epileptic seizure that could serve as possible biomarkers, allowing for accurate diagnosis of epilepsy using a simple blood test.

Researchers from Lund University (Lund, Sweden) began looking for potential biomarkers for epilepsy within the immune system as the inflammation processes that begin as an immune response in the body are also capable of provoking a seizure. The researchers also conducted a comparative analysis of epileptic seizures with psychogenic non-epileptic seizures which is a psychiatric diagnosis that can exhibit clinical symptoms closely resembling those witnessed in epilepsy, thus leading to frequent misdiagnosis. Psychogenic seizure is a chronic disorder that remains underdiagnosed and is usually erroneously treated with epilepsy medication. As such, there is a compelling need for a more straightforward differentiation method between the two conditions.

By analyzing the blood samples of individuals who recently experienced epileptic seizures, researchers identified a significant increase in the levels of five distinct inflammation markers or proteins. Conversely, for individuals experiencing psychogenic seizures, there was no notable variation in the biomarker concentration. This suggests that a simple blood test administered to patients arriving at the emergency room following a seizure could reveal elevated immunological responses, indicating the possibility of an epileptic seizure. In contrast, if these biomarker levels are normal, there is a greater likelihood of a psychogenic seizure, thereby offering an initial indication of how the patient should be evaluated further.

“We call these markers ‘fingerprints’ since they involve several inflammation-related proteins with different reaction patterns,” said Marie Taylor, physician, and doctoral student in the research team. “The patients who had epilepsy showed raised levels of one of the five proteins – IL-6 – even before their seizures, a value that transiently raised even further directly after the seizure.”

“The next stage is to repeat our studies on a broader and less homogenous patient group, where we investigate the ‘fingerprint’ in adults with epilepsy,” added Christine Ekdahl Clementson, group leader, and associate professor at Lund University. “We also want to see whether the biomarkers respond in the same way in children, where the causes of epilepsy are more often genetic.”

Related Links:
Lund University 

New
Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
Automated Staining Unit
RAL Stainer
New
Respiratory Infections Test
NeoPlex RB-8 Detection Kit
New
Countertop Platelet Incubator
PC900-Pro

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Hematology

view channel
Image: The latest FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer (Photo courtesy of PixCell)

True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

An innovative 5-part differential Complete Blood Count (CBC) analyzer with direct capillary sampling capability significantly simplifies blood sampling and minimizes the pre-analytical process.... Read more

Immunology

view channel
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell,... Read more

Microbiology

view channel
Image: On-chip pretreatment and rapid AST based directly on positive blood cultures (Photo courtesy of Liu Yang)

Integrated Solution for Rapid AST Directly From Positive Blood Cultures to Combat Bloodstream Infection

The presence of living bacteria in the bloodstream, known as bacteremia, can lead to serious conditions like bloodstream infections (BSIs) and sepsis, which can often be fatal. Quickly prescribing the... Read more

Pathology

view channel
Image: The Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models (Photo courtesy of Gestalt Diagnostics)

New AI Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models

A new artificial intelligence (AI) algorithm for use on one of the broadest trained environments is now available for commercial or research work. Gestalt Diagnostics (Spokane, WA, USA) has released the... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.